Evidence map›Paper›PMID 30137694›Full record

ArticleChembiochem : a European journal of chemical biology2019

A Conditionally Fluorescent Peptide Reporter of Secondary Structure Modulation.

Oleta T Johnson, Tanpreet Kaur, Amanda L Garner

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oleta T JohnsonProgram in Chemical Biology, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI, 48109, USA.
Tanpreet KaurDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, 1600 Huron Parkway, NCRC B520, Ann Arbor, MI, 48109, USA.
Amanda L GarnerProgram in Chemical Biology, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-0870-3347

Funding

MICHIGAN CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008597 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN · 1996 to 2018
$5.0M
4E-BP Mimetics as Chemical Probes for Studying Translational Control in CancerR01CA202018 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARNER, AMANDA · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA202018NIGMS NIH HHS T32 GM008597
6 · The paper itself

Abstract

Proteins containing intrinsic disorder often form secondary structure upon interaction with a binding partner. Modulating such structures presents an approach for manipulating the resultant functional outcomes. Translational repressor protein 4E-BP1 is an example of an intrinsically disordered protein that forms an α-helix upon binding to its protein ligand, eIF4E. Current biophysical methods for analyzing binding-induced structural changes are low-throughput, require large amounts of sample, or are extremely sensitive to signal interference by the ligand itself. Herein, we describe the discovery and development of a conditionally fluorescent 4E-BP1 peptide that reports structural changes of its helix in high-throughput format. This reporter peptide is based on conditional quenching of fluorescein by thioamides. In this case, fluorescence signal increases as the peptide becomes more ordered. Conversely, destabilization of the α-helix results in decreased fluorescence signal. The low concentration and low volume of peptide required make this approach amenable for high-throughput screening to discover ligands that alter peptide secondary structure.

Indexed as

Amino Acid SequenceCarrier ProteinsEukaryotic Initiation Factor-4EFluorescein-5-isothiocyanateFluorescent DyesHumansPeptidesProtein Conformation, alpha-HelicalProtein FoldingThioamidesCarrier ProteinsEIF4E protein, humanEukaryotic Initiation Factor-4EFluorescein-5-isothiocyanateFluorescent DyesPeptidesThioamidesbioorganic chemistryfluorescent probeshelical structureshigh-throughput screeningprotein folding

Identifiers

PMID30137694
PMCPMC6482830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.